Clinical Trial Update: Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating network-targeted neuromodulation for nicotine dependence in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Schizophrenia, Nicotine Dependence | NA | Status: COMPLETED